Figures & data
Table 1. Eligibility Criteria.
Table 2. Characteristics of included studies.
Table 3. Risk of bias assessment.
Figure 2a. Forest plot: Overall MSK and NCD comorbidities with indications of overall risk of bias per study.
![Figure 2a. Forest plot: Overall MSK and NCD comorbidities with indications of overall risk of bias per study.](/cms/asset/c237e9c1-f66d-4e20-8f29-5217679544b6/rhpe_a_2332911_f0002a_oc.jpg)
Figure 3. Forest Plot: MSK prevalence with comorbid Hypertension with indications of overall risk of bias per study.
![Figure 3. Forest Plot: MSK prevalence with comorbid Hypertension with indications of overall risk of bias per study.](/cms/asset/7af7b54f-bd98-4c72-8708-8136e82f7105/rhpe_a_2332911_f0003_oc.jpg)
Figure 4. Forest Plot: MSK prevalence with comorbid Diabetes with indications of overall risk of bias per study.
![Figure 4. Forest Plot: MSK prevalence with comorbid Diabetes with indications of overall risk of bias per study.](/cms/asset/b194f059-5e4f-4cfe-92c2-ee55620fa3cb/rhpe_a_2332911_f0004_oc.jpg)
Figure 5. Forest Plot: MSK prevalence with comorbid Depression and Anxiety with indications of overall risk of bias per study.
![Figure 5. Forest Plot: MSK prevalence with comorbid Depression and Anxiety with indications of overall risk of bias per study.](/cms/asset/6f997b3c-5981-4856-aa2b-ed7eb123026a/rhpe_a_2332911_f0005_oc.jpg)
Figure 6. Forest Plot: Subgroup analysis of comorbid NCDs with specific MSK Pain (i.e. hip/knee OA and LBP) with indications of overall risk of bias per study.
![Figure 6. Forest Plot: Subgroup analysis of comorbid NCDs with specific MSK Pain (i.e. hip/knee OA and LBP) with indications of overall risk of bias per study.](/cms/asset/c458a490-573e-4aa6-b776-4087f147b498/rhpe_a_2332911_f0006_oc.jpg)